The Liver Cancer Treatment Drug Market continues to expand as the global incidence of hepatocellular carcinoma and other liver malignancies rises in tandem with increasing prevalence of hepatitis infections, non-alcoholic fatty liver disease, and alcohol-related liver damage. With liver cancer ranking among the leading causes of cancer-related mortality worldwide, the demand for effective...